MediVet America, LLC – Trademark Portfolio
Entity Type: 16
MediVet America, LLC holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 8 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include K9-ACV and ACTI-STEM. The owner is based in Nicholasville, KY.
200 Moore Dr
Nicholasville, KY 40356
Showing of trademarks Trademarks
Trademark Classifications
MediVet America, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does MediVet America, LLC have?
MediVet America, LLC has 9 U.S. trademarks filed with the USPTO. Of these, 2 registered, 4 abandoned, 3 cancelled.
What trademark classes does MediVet America, LLC file in?
MediVet America, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are MediVet America, LLC's most well-known trademarks?
MediVet America, LLC's registered trademark portfolio includes well-known marks such as K9-ACV and ACTI-STEM. These are among 2 currently registered trademarks in the portfolio.
What is MediVet America, LLC's trademark registration success rate?
MediVet America, LLC has a 22% trademark registration rate, with 2 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.